Background: To assess the functional involvement of the central nervous system (CNS) via quantitative electroencephalography (EEG) analysis in children with mild to moderate COVID-19 infection who were otherwise previously healthy children.
Objective: To calculate epilepsy-related direct, indirect, and total costs in adult patients with active epilepsy (ongoing unprovoked seizures) in Germany and to analyze cost components and dynamics compared to previous studies from 2003, 2008 and 2013.
Researchers from Otago and Okinawa Institute of Science and Technology Graduate University have developed a new system that uses specialized sound waves (above the frequency that we can hear) or light (above the wavelength that we can see) to release medication into specific areas of the brain to stop seizure activity.
Our aim was to identify novel epilepsy-specific autoantibodies reactive with neuronal surface antigens.
The polygenic burden for schizophrenia is a risk factor for levetiracetam-associated psychotic reaction.
Currently, there is no effective treatment or cure for PTE; therefore, there is a critical need to develop animal models to help further understand and assess the mechanisms and interventions related to TBI-induced epilepsy.
To characterize antiseizure medication (ASM) treatment pathways in Medicare beneficiaries with newly treated epilepsy.
The primary purpose is to determine if the time between epilepsy surgery and first seizure recurrence can estimate the timing of the next seizure event for temporal and extratemporal epilepsy.
